TCRX
TScan Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TCRX fundamentals
TScan Therapeutics (TCRX) released its earnings on Aug 12, 2025: revenue was 3.08M (YoY +474.63%), beat estimates; EPS was -0.28 (YoY 0.00%), beat estimates.
Revenue / YoY
3.08M
+474.63%
EPS / YoY
-0.28
0.00%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 11, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
TCRX has released its 2025 Q3 earnings report, with revenue of 2.51M, reflecting a YoY change of 139.37%, and net profit of -35.71M, showing a YoY change of -19.48%. The Sankey diagram below clearly presents TCRX's revenue sources and cost distribution.
Key Indicators
TScan Therapeutics (TCRX) key financial stats and ratios, covering profitability, financial health, and leverage.
TScan Therapeutics (TCRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
TScan Therapeutics (TCRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
TScan Therapeutics (TCRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does TScan Therapeutics (TCRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track TScan Therapeutics (TCRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did TScan Therapeutics beat or miss consensus estimates last quarter?What is TScan Therapeutics's gross profit margin?What were the key takeaways from TScan Therapeutics's earnings call?What is TScan Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for TScan Therapeutics year over year?What is the market's earnings forecast for TScan Therapeutics next quarter?What factors drove the changes in TScan Therapeutics's revenue and profit?What were the key takeaways from TScan Therapeutics’s earnings call?
